Flugen, Inc. Secures Exclusive Rights to Novel Vaccine-Delivery Technology

Published: Mar 24, 2009

MADISON, Wis.--(BUSINESS WIRE)--FluGen Inc., an emerging leader in the development, production and delivery of influenza vaccines and related products, today announced it has secured exclusive rights to a novel, patent-protected vaccine-delivery technology being commercialized by Madison, Wis.-based Ratio Inc. Terms of the license agreement were not disclosed.

Back to news